Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A1 | P13866 | 8/20 | 1.00 |
| ▸ | SLC5A2 | P31639 | 8/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.78 |
| ▸ | MAPT | P10636 | 3/20 | 0.78 |
| ▸ | MEN1 | O00255 | 3/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.78 |
| ▸ | GAA | P10253 | 2/20 | 0.78 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.78 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.78 |
| ▸ | RELA | Q04206 | 2/20 | 0.78 |
| ▸ | HPGD | P15428 | 2/20 | 0.78 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.78 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.78 |
| ▸ | LMNA | P02545 | 1/20 | 0.78 |
| ▸ | TTR | P02766 | 1/20 | 0.78 |
| ▸ | ESR1 | P03372 | 1/20 | 0.78 |
| ▸ | TP53 | P04637 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18306234 | 0.92 | SLC5A1 (0.84) | SLC5A1SLC5A2CYP19A1MAPTMEN1 | |
| SCHEMBL15457885 | 0.89 | NFKB1 (0.83) | SLC5A1SLC5A2CYP19A1MAPTMEN1 | |
| Phloretin SCHEMBL27910960 | 0.88 | SLC5A1 (0.93) | SLC5A1SLC5A2CYP19A1MAPTMEN1 | |
| Phloretin SCHEMBL38131 | 0.88 | SLC5A1 (1.00) | SLC5A1SLC5A2CYP19A1MAPTMEN1 | |
| Phloretin SCHEMBL1506325 | 0.88 | SLC5A1 (1.00) | SLC5A1SLC5A2CYP19A1MAPTMEN1 | |
| SCHEMBL26244512 | 0.87 | SLC5A1 (0.78) | SLC5A1SLC5A2CYP19A1MAPTMEN1 | |
| SCHEMBL15094538 | 0.87 | SLC5A1 (0.78) | SLC5A1SLC5A2CYP19A1MAPTMEN1 | |
| Phloretin SCHEMBL30912872 | 0.86 | SLC5A1 (0.96) | SLC5A1SLC5A2CYP19A1MAPTMEN1 | |
| Phloretin SCHEMBL30785809 | 0.86 | SLC5A1 (0.96) | SLC5A1SLC5A2CYP19A1MAPTMEN1 | |
| Phloretin SCHEMBL31684375 | 0.86 | SLC5A1 (0.96) | SLC5A1SLC5A2CYP19A1MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10800725-B2 | Arylpropionyl-triketone antibacterial agents | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2020-10-13 | — | — | US | disclosed |
| US-20180142216-A1 | Biosynthesis of Phenylpropanoid and Dihydrophenylpropanoid Derivatives | DANSTAR FERMENT AG (CH) | 2018-05-24 | — | — | US | disclosed |
| US-20170295827-A1 | BEVERAGES CONTAINING RARE SUGARS | THE COCA-COLA COMPANY | 2017-10-19 | — | — | US | disclosed |
| US-9717267-B2 | Beverages containing rare sugars | THE COCA-COLA COMPANY (US) | 2017-08-01 | — | — | US | disclosed |
| US-9517994-B2 | Antibacterial agents: phloroglucinol derivatives | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2016-12-13 | — | — | US | disclosed |
| US-20160279084-A1 | TARGETED TREATMENT OF ANEROBIC CANCER | UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER | 2016-09-29 | — | — | US | disclosed |
| US-20150011647-A1 | ANTIBACTERIAL AGENTS: PHLOROGLUCINOL DERIVATIVES | HOWARD HUGHES MEDICAL INSTITUTE | 2015-01-08 | — | — | US | disclosed |
| US-20140272068-A1 | BEVERAGES CONTAINING RARE SUGARS | THE COCA-COLA COMPANY | 2014-09-18 | — | — | US | disclosed |
| US-20140271996-A1 | BEVERAGES CONTAINING RARE SUGARS | THE COCA-COLA COMPANY | 2014-09-18 | — | — | US | disclosed |
| US-20130289128-A1 | ARYLPROPIONYL-TRIKETONE ANTIBACTERIAL AGENTS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2013-10-31 | — | — | US | disclosed |
| US-8227426-B2 | Chiral complexes of ascorbic acid with natural antioxidant and anti-inflammatory ketones including aloe, citrus, ginger, and mango for skin and hair care | ISLAND KINETICS INC. (US) | 2012-07-24 | — | — | US | disclosed |
| WO-2012033846-A1 | ARYLPROPIONYL-TRIKETONE ANTIBACTERIAL AGENTS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2012-03-15 | — | — | WO | disclosed |
| US-20110059907-A1 | Chiral Complexes of Ascorbic Acid with Natural Antioxidant and Anti-Inflammatory Ketones Including Aloe, Citrus, Ginger, and Mango for Skin and Hair Care | ISLAND KINETICS INC. (US) | 2011-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110059907-A1 | Chiral Complexes of Ascorbic Acid with Natural Antioxidant and Anti-Inflammatory Ketones Including Aloe, Citrus, Ginger, and Mango for Skin and Hair Care | GLA, LPO, PLOD3 | SLC5A1 3886/4885SLC5A2 3603/4885CYP19A1 104/4885 |
| US-20130289128-A1 | ARYLPROPIONYL-TRIKETONE ANTIBACTERIAL AGENTS | POLR2H, POLR2A, POLR2E | SLC5A1 2423/4885SLC5A2 3409/4885CYP19A1 3134/4885 |
| US-20150011647-A1 | ANTIBACTERIAL AGENTS: PHLOROGLUCINOL DERIVATIVES | BET1, MRPL21, PHF6 | SLC5A1 41/4885SLC5A2 78/4885CYP19A1 3913/4885 |
| US-10800725-B2 | Arylpropionyl-triketone antibacterial agents | POLR2H, POLR2A, POLR2E | SLC5A1 2423/4885SLC5A2 3409/4885CYP19A1 3134/4885 |
| US-20160279084-A1 | TARGETED TREATMENT OF ANEROBIC CANCER | SLC16A3, SLC16A1, SLC16A7 | SLC5A1 76/4885SLC5A2 69/4885CYP19A1 2168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.